219 related articles for article (PubMed ID: 32894005)
21. [A case of malignant pleural mesothelioma with gastrointestinal metastases which were diagnosed by endoscopic biopsy].
Terashita S; Hirano K; Hirai T; Narabayashi T; Hara Y; Mori H; Endo K; Hirabayashi M
Nihon Kokyuki Gakkai Zasshi; 2009 Feb; 47(2):133-8. PubMed ID: 19260537
[TBL] [Abstract][Full Text] [Related]
22. Cytokine/Chemokine/Growth Factor Levels in Malignant Pleural Effusion of Non-small Cell Lung Cancer.
Hayama N; Hattori S; Takahashi G; Takahashi F; Takeuchi T; Tanaka J; Horio Y; Takiguchi H; Tomomatsu K; Kitahara A; Takihara T; Niimi K; Oguma T; Asano K
Tokai J Exp Clin Med; 2020 Dec; 45(4):224-229. PubMed ID: 33300594
[TBL] [Abstract][Full Text] [Related]
23. miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology.
Cappellesso R; Galasso M; Nicolè L; Dabrilli P; Volinia S; Fassina A
Cancer Cytopathol; 2017 Aug; 125(8):635-643. PubMed ID: 28449331
[TBL] [Abstract][Full Text] [Related]
24. The Prevalence and Clinical Relevance of Nonexpandable Lung in Malignant Pleural Mesothelioma. A Prospective, Single-Center Cohort Study of 229 Patients.
Bibby AC; Halford P; De Fonseka D; Morley AJ; Smith S; Maskell NA
Ann Am Thorac Soc; 2019 Oct; 16(10):1273-1279. PubMed ID: 31189069
[No Abstract] [Full Text] [Related]
25. Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
Hwang HC; Sheffield BS; Rodriguez S; Thompson K; Tse CH; Gown AM; Churg A
Am J Surg Pathol; 2016 Jan; 40(1):120-6. PubMed ID: 26448191
[TBL] [Abstract][Full Text] [Related]
26. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.
Holloway AJ; Diyagama DS; Opeskin K; Creaney J; Robinson BW; Lake RA; Bowtell DD
Clin Cancer Res; 2006 Sep; 12(17):5129-35. PubMed ID: 16951230
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of medical thoracoscopy in malignant pleural effusion.
Wu YB; Xu LL; Wang XJ; Wang Z; Zhang J; Tong ZH; Shi HZ
BMC Pulm Med; 2017 Aug; 17(1):109. PubMed ID: 28778184
[TBL] [Abstract][Full Text] [Related]
28. [A case of malignant mesothelioma showing rapid progression during one month].
Hara H; Tamura A; Suzuki J; Masuda K; Nagai H; Akagawa S; Kawabe Y; Nagayama N; Machida K; Kurashima A; Sagara Y; Komatsu H; Yotsumoto H; Hebisawa A; Kimura A
Nihon Kokyuki Gakkai Zasshi; 2005 Jul; 43(7):417-21. PubMed ID: 16050468
[TBL] [Abstract][Full Text] [Related]
29. [Localized fibrous mesothelioma with bloody pleural effusion; report of a case].
Ogata K; Sakakibara K; Hirano R; Nishiumi N; Tsutsumi M; Ishihara S; Namikawa S
Kyobu Geka; 2004 Feb; 57(2):159-62. PubMed ID: 14978915
[TBL] [Abstract][Full Text] [Related]
30. A Man in His 20s With Cough, Unilateral Pleural Effusion, and Nodular Pleural Thickening.
Sonnick MA; Weisman S; Borczuk AC; Turetz ML
Chest; 2019 Dec; 156(6):e121-e126. PubMed ID: 31812210
[TBL] [Abstract][Full Text] [Related]
31. Amelanotic Malignant Melanoma with Dense Pleural Thickening Mimicking Malignant Mesothelioma.
Saraya T; Fujiwara M; Morita K; Watanabe T; Ogawa Y; Takizawa H; Light RW
Intern Med; 2019 Apr; 58(7):969-972. PubMed ID: 30449771
[TBL] [Abstract][Full Text] [Related]
32. Useful Application of Immunostaining to Malignant Pleural Effusion among Lao People in Vientiane Capital, Lao PDR.
Vilayvong S; Hando K; Sekine M; Luangxay T; Arounlangsy P; Xaysomphet P; Xayaphet P; Thavisouk H; Soejima Y; Kitagawa M; Sawabe M
Asian Pac J Cancer Prev; 2019 Jan; 20(1):243-248. PubMed ID: 30678439
[TBL] [Abstract][Full Text] [Related]
33. The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma.
Lovrenski A; Panjković M; Tegeltija D; Latinović LT; Krcedinac J
Med Pregl; 2012; 65(1-2):5-8. PubMed ID: 22452231
[TBL] [Abstract][Full Text] [Related]
34. Fibrinolysis of loculated pleural effusion in malignant mesothelioma.
Balamugesh T; Christopher DJ; Rajesh T; Prince J
Singapore Med J; 2004 Dec; 45(12):594-5. PubMed ID: 15568123
[TBL] [Abstract][Full Text] [Related]
35. K-ras and rho A mutations in malignant pleural effusion.
Nakamoto M; Teramoto H; Matsumoto S; Igishi T; Shimizu E
Int J Oncol; 2001 Nov; 19(5):971-6. PubMed ID: 11604996
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F
Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic MTAP expression loss detected by immunohistochemistry correlates with 9p21 homozygous deletion detected by FISH in pleural effusion cytology of mesothelioma.
Hamasaki M; Kinoshita Y; Yoshimura M; Matsumoto S; Kamei T; Hiroshima K; Sato A; Tsujimura T; Kawahara K; Nabeshima K
Histopathology; 2019 Jul; 75(1):153-155. PubMed ID: 30957899
[No Abstract] [Full Text] [Related]
38. Diffuse intrapulmonary malignant mesothelioma presenting with miliary pulmonary nodules: A case report.
Hida T; Hamasaki M; Matsumoto S; Abe S; Takakura K; Hiroshima K; Nabeshima K
Pathol Int; 2015 Jun; 65(6):318-23. PubMed ID: 25759091
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.
Ak G; Tomaszek SC; Kosari F; Metintas M; Jett JR; Metintas S; Yildirim H; Dundar E; Dong J; Aubry MC; Wigle DA; Thomas CF
Biomed Res Int; 2015; 2015():635748. PubMed ID: 25756049
[TBL] [Abstract][Full Text] [Related]
40. Two familial mesothelioma cases with high concentrations of soluble cytokeratin 19 fragment in pleural fluid.
Hiyama J; Marukawa M; Shiota Y; Ono T; Imai S; Motohiro K; Aoki J; Sasaki N; Taniyama K; Mashiba H
Intern Med; 1998 Apr; 37(4):407-10. PubMed ID: 9630204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
